Research Topics
Species | Andres J M FerreriSummaryAffiliation: San Raffaele Scientific Institute Country: Italy Publications
| Collaborators
|
Detail Information
Publications
Primary CNS lymphomaAndres J M Ferreri
Unit of Lymphoid Malignancies, Department of Onco Hematology, San Raffaele Scientific Institute, Milan, Italy
Best Pract Res Clin Haematol 25:119-30. 2012..Future therapeutic progresses in PCNSL will be based on the expansion of molecular and biological knowledge, the improvement of therapeutic efficacy and the prevention of iatrogenic neurotoxicity...
How I treat primary CNS lymphomaAndres J M Ferreri
Unit of Lymphoid Malignancies, Department of Onco Hematology, San Raffaele Scientific Institute, Milan, Italy
Blood 118:510-22. 2011..Herein, these important contributions are analyzed to provide recommendations for everyday practice and the rationale for future trials...
Anaplastic large cell lymphoma, ALK-negativeAndres J M Ferreri
Unit of Lymphoid Malignancies, Department of Onco Hematology, San Raffaele Scientific Institute, Milan, Italy Electronic address
Crit Rev Oncol Hematol 85:206-15. 2013....
Anaplastic large cell lymphoma, ALK-positiveAndres J M Ferreri
Unit of Lymphoid Malignancies, San Raffaele Scientific Institute, Milan, Italy
Crit Rev Oncol Hematol 83:293-302. 2012..Recently, the development of novel therapies targeting CD30 and ALK appear promising...
Hepatosplenic gamma-delta T-cell lymphomaAndres J M Ferreri
Unit of Lymphoid Malignancies, Department of Onco Hematology, San Raffaele Scientific Institute, Milan, Italy
Crit Rev Oncol Hematol 83:283-92. 2012..The use of 2'-deoxycoformycin and other targeted therapies, such as alemtuzumab, anti-γδ TCR monoclonal antibodies, and anti-CD44 therapy, have shown promising results in anecdotal reports...
Consolidation radiotherapy in primary central nervous system lymphomas: impact on outcome of different fields and doses in patients in complete remission after upfront chemotherapyAndrés José María Ferreri
Unit of Lymphoid Malignancies, Department of Oncology, San Raffaele Scientific Institute, Milan, Italy
Int J Radiat Oncol Biol Phys 80:169-75. 2011..Nevertheless, no study has focused on the survival impact of radiation parameters, as far as we know, and the optimal radiation schedule remains to be defined...
Re-occurrence of the CD20 molecule expression subsequent to CD20-negative relapse in diffuse large B-cell lymphomaA J Ferreri
Medical Oncology Unit, Dept of Oncology, San Raffaele H Scientific Institute, Milan, Italy
Haematologica 92:e1-2. 2007..Accordingly, every relapse, whenever possible, should be histologically assessed with diagnostic and immunophenotyping purposes...
Primary diffuse large B-cell lymphoma of the stomachAndres J M Ferreri
Medical Oncology Unit, San Raffaele Scientific Institute, Milan, Italy
Crit Rev Oncol Hematol 63:65-71. 2007..Several questions on the best treatment remain unanswered. Among others, the role of rituximab, consolidation radiotherapy as well as of more conservative approaches like H. pylori-eradicating antibiotic therapy should be better defined...
Enteropathy-associated T-cell lymphomaAndres J M Ferreri
Unit of Lymphoid Malignancies, Department of Oncology, San Raffaele Scientific Institute, Milan, Italy
Crit Rev Oncol Hematol 79:84-90. 2011..Moreover, the high incidence of severe postsurgical complications and the poor nutritional and immunological conditions lead to progressive deterioration of these patients, preventing the use of an adequate and effective treatment...
Bacteria-eradicating therapy with doxycycline in ocular adnexal MALT lymphoma: a multicenter prospective trialAndres J M Ferreri
Medical Oncology Unit, Department of Oncology, San Raffaele H Scientific Institute, Via Olgettina 60, 20132 Milan, Italy
J Natl Cancer Inst 98:1375-82. 2006..The effectiveness of doxycycline treatment in Cp-negative OAL has not been tested...
Hematologic malignancies: from clinical science to clinical practice - 2nd European CongressAndres J M Ferreri
Medical Oncology Unit, San Raffaele H Scientific Institute, Via Olgettina 60, 20132 Milan, Italy
IDrugs 9:242-6. 2006
Clinical implications of hepatitis C virus infection in MALT-type lymphoma of the ocular adnexaA J M Ferreri
Medical Oncology Unit, San Raffaele H Scientific Institute, Milan, Italy
Ann Oncol 17:769-72. 2006..A pathogenic link between hepatitis C virus (HCV) and MALT-type lymphomas has been suggested. However, studies assessing the role of HCV infection separately in different forms of MALT lymphomas are not available...
Central nervous system dissemination in immunocompetent patients with aggressive lymphomas: incidence, risk factors and therapeutic optionsAndres J M Ferreri
Unit of Lymphoid Malignancies, Department of Oncology, San Raffaele H Scientific Institute, Milan, Italy
Hematol Oncol 27:61-70. 2009....
Marginal-zone lymphomaAndres J M Ferreri
Medical Oncology Unit, Department of Oncology, San Raffaele Scientific Institute, Milan, Italy
Crit Rev Oncol Hematol 63:245-56. 2007..However, prospective trials on these malignancies are rare and universally accepted therapeutic guidelines do not exist. MZLs constitute an exciting investigational setting both from molecular and clinical points of view...
Primary central nervous system lymphomaAndres J M Ferreri
Medical Oncology Unit, San Raffaele Scientific Institute, Milan, Italy
Crit Rev Oncol Hematol 63:257-68. 2007..Although studies published on PCNSL are increasing, several therapeutic questions still remain unanswered after a decade of research...
Chlamydial infection: the link with ocular adnexal lymphomasAndres J M Ferreri
Unit of Lymphoid Malignancies, San Raffaele Scientific Institute, Milan, Italy
Nat Rev Clin Oncol 6:658-69. 2009..Available data on the epidemiology, biology and pathogenesis of this association are analyzed and new investigative and clinical approaches are discussed...
Ocular adnexal MALT lymphoma: an intriguing model for antigen-driven lymphomagenesis and microbial-targeted therapyA J M Ferreri
Unit of Lymphoid Malignancies, Department of Oncology, San Raffaele Scientific Institute, Milan, Italy
Ann Oncol 19:835-46. 2008..In this review, we analyze the most relevant biological, molecular, pathological and clinical features of OAML and propose some therapeutic guidelines for patients affected by this malignancy...
High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trialAndres J M Ferreri
Unit of Lymphoid Malignancies, San Raffaele Scientific Institute, Milan, Italy
Lancet 374:1512-20. 2009..We assessed the effect of adding high-dose cytarabine to methotrexate in patients with newly diagnosed primary CNS lymphoma...
Chlamydophila psittaci is viable and infectious in the conjunctiva and peripheral blood of patients with ocular adnexal lymphoma: results of a single-center prospective case-control studyAndres J M Ferreri
Unit of Lymphoid Malignancies, San Raffaele Scientific Institute, Milan, Italy
Int J Cancer 123:1089-93. 2008..Cp infection is common in OAML patients and exceptional in blood donors. Epidemiological data of OAML patients (prolonged contact with household animals and chronic conjunctivitis) are consistent with Cp exposure risk...
Infectious agents and lymphoma development: molecular and clinical aspectsA J M Ferreri
Unit of Lymphoid Malignancies, Medical Oncology Unit, Department of Oncology, San Raffaele Scientific Institute, Milan, Italy
J Intern Med 265:421-38. 2009..Molecular, biological and clinical features as well as therapeutic implications of these associations are analysed and future perspectives in this field are discussed...
High-dose chemotherapy supported by autologous stem cell transplantation in patients with primary central nervous system lymphoma: facts and opinionsAndres J M Ferreri
Unit of Lymphoid Malignancies, Medical Oncology Unit, Department of Oncology, San Raffaele Scientific Institute, Milan, Italy
Leuk Lymphoma 49:2042-7. 2008..This critical review is focused on the analysis of published experiences on HDC/ASCT in PCNSL in order to provide preliminary answers to the most pressing questions in this field...
Intralesional rituximab: a new therapeutic approach for patients with conjunctival lymphomasAndres J M Ferreri
Unit of Lymphoid Malignancies, Department of Oncology, San Raffaele Scientific Institute, Milan, Italy
Ophthalmology 118:24-8. 2011..Intralesional administration of this drug has increased local disease control in cases of cutaneous mucosa-associated lymphoid tissue (MALT) lymphoma...
Regression of ocular adnexal lymphoma after Chlamydia psittaci-eradicating antibiotic therapyAndres J M Ferreri
Department of Radiochemotherapy, San Raffaele H Scientific Institute, Via Olgettina 60, 20132 Milan, Italy
J Clin Oncol 23:5067-73. 2005..The present pilot study was carried out to assess whether C psittaci-eradicating antibiotic therapy is associated with tumor regression in ocular adnexal lymphomas...
Therapeutic management of primary central nervous system lymphoma: lessons from prospective trialsA J Ferreri
Department of Radiochemotherapy, San Raffaele H Scientific Institute, Milan, Italy
Ann Oncol 11:927-37. 2000..The assessment of impact of treatment on neuropsychological functions and quality of life is a mandatory endpoint in clinical trials...
Combined treatment with high-dose methotrexate, vincristine and procarbazine, without intrathecal chemotherapy, followed by consolidation radiotherapy for primary central nervous system lymphoma in immunocompetent patientsA J Ferreri
Department of Radiochemotherapy, San Raffaele H Scientific Institute, Milan, Italy
Oncology 60:134-40. 2001..Patients who achieved a complete remission were referred to RT, those with progressive disease were excluded from further study; all the remaining patients received a third course of CHT followed by RT...
Immunoreactivity for p27(KIP1) and cyclin E is an independent predictor of survival in primary gastric non-Hodgkin's lymphomaA J Ferreri
Department of Radiochemotherapy, San Raffaele H Scientific Institute, Milan, Italy
Int J Cancer 94:599-604. 2001..The predictive role of these molecules within each histologic group of PGLs deserves to be confirmed in larger series...
A multicenter study of treatment of primary CNS lymphomaA J M Ferreri
Department of Radiochemotherapy, San Raffaele H Scientific Institute, Milan, Italy
Neurology 58:1513-20. 2002..To characterize the therapeutic variables correlated to outcome in 370 patients with primary CNS lymphoma...
Relevance of intraocular involvement in the management of primary central nervous system lymphomasA J M Ferreri
Department of Radiochemotherapy, San Raffaele H Scientific Institute, Milan, Italy
Ann Oncol 13:531-8. 2002..Reported data regarding intraocular lymphoma (IOL) management are anecdotal. Cases of IOL included in an international multicentre series of 378 immunocompetent patients with primary central nervous system lymphomas (PCNSLs) were reviewed...
Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experienceAndres J M Ferreri
Department of Radiochemotherapy, San Raffaele H Scientific Institute, Milan, Italy
J Clin Oncol 21:266-72. 2003..To identify survival predictors and to design a prognostic score useful for distinguishing risk groups in immunocompetent patients with primary CNS lymphomas (PCNSL)...
Summary statement on primary central nervous system lymphomas from the Eighth International Conference on Malignant Lymphoma, Lugano, Switzerland, June 12 to 15, 2002Andres J M Ferreri
Department of Radiochemotherapy, San Raffaele H Scientific Institute, Via Olgettina 60, 20132, Milan, Italy
J Clin Oncol 21:2407-14. 2003..This article summarizes the contents of the Workshop, analyzes the current knowledge on the most relevant biologic and clinical issues in PCNSL, and focuses on fundamental challenges to be addressed in future studies...
Consolidation radiotherapy to bulky or semibulky lesions in the management of stage III-IV diffuse large B cell lymphomasA J Ferreri
Department of Radiochemotherapy, San Raffaele H Scientific Institute, Milan, Italy
Oncology 58:219-26. 2000..To assess the impact on survival of consolidation radiotherapy to bulky or semibulky lesions in patients with advanced diffuse large B cell lymphoma (DLCL) in complete remission after primary chemotherapy...
Anthracycline-based chemotherapy as primary treatment for intravascular lymphomaA J M Ferreri
Department of Radiochemotherapy, San Raffaele H Scientific Institute, Milan, Italy
Ann Oncol 15:1215-21. 2004..Optimal therapeutic management of intravascular lymphoma (IVL) lacks precise guidelines...
Clinical relevance of the dose of cytarabine in the upfront treatment of primary CNS lymphomas with methotrexate-cytarabine combinationAndres J M Ferreri
Department of Oncology, San Raffaele Scientific Institute, Via Olgettina 60, 20132 Milan, Italy
Oncologist 16:336-41. 2011..With respect to MTX-araC combination, araC dose was halved to minimize toxicity. Herein, we report tolerability, activity, and efficacy of MAT regimen and compare these results to those previously reported with MTX/ara-C combination...
Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomasAndres J M Ferreri
Department of Radiochemotherapy, San Raffaele H Scientific Institute, Milan, Italy
J Natl Cancer Inst 96:586-94. 2004..Hence, we assessed whether Chlamydiae infection is associated with the development of ocular adnexal lymphomas...
The addition of rituximab to anthracycline-based chemotherapy significantly improves outcome in 'Western' patients with intravascular large B-cell lymphomaAndres J M Ferreri
Unit of Lymphoid Malignancies and Medical Oncology Unit, Department of Oncology, San Raffaele H Scientific Institute, Milano, Italy
Br J Haematol 143:253-7. 2008..50%; P = 0.04), event-free survival (3-year: 89% vs. 35%; P = 0.003) and overall survival (3-year: 89% vs. 38%; P = 0.01). In conclusion, rituximab may substantially change the dismal prognosis of IVL...
Chlamydia infection and lymphomas: association beyond ocular adnexal lymphomas highlighted by multiple detection methodsMaurilio Ponzoni
Pathology Unit, San Raffaele Scientific Institute, Milano, Italy
Clin Cancer Res 14:5794-800. 2008..Herein, we used multiple Chlamydia detection tools to identify Cp elementary bodies-containing cell and to assess Cp prevalence in both nodal and extranodal lymphomas...
Treatment approaches for primary CNS lymphomasMatteo G Carrabba
San Raffaele Scientific Institute, Haematology and Bone Marrow Transplantation Unit, Department of Oncology, Milan, Italy
Expert Opin Pharmacother 11:1263-76. 2010..The overall outcome for PCNSL patients is unsatisfactory and several therapeutic questions remain open. Modest progress in outcome reflects difficulties in conducting randomized trials and scarce molecular and biological knowledge...
Variations in clinical presentation, frequency of hemophagocytosis and clinical behavior of intravascular lymphoma diagnosed in different geographical regionsAndres J M Ferreri
Medical Oncology Unit, Department of Oncology, San Raffaele Scientific Institute, Milan, Italy
Haematologica 92:486-92. 2007..This study explored variations in the clinical manifestations of intravascular lymphoma (IVL) on the bases of the association with hemophagocytosis and the country where the diagnosis was made...
Questions and answers in the management of primary central nervous system and ocular lymphomasAndres J M Ferreri
Department of Radiochemotherapy, San Raffaele H Scientific Institute, Via Olgettina 60, 20132 Milan, Italy
Haematologica 88:1063-8. 2003
Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the 'cutaneous variant'Andres J M Ferreri
Department of Radiochemotherapy, San Raffaele H Scientific Institute, Milan, Italy
Br J Haematol 127:173-83. 2004..ECOG-PS >1, 'cutaneous variant', stage I and chemotherapy use were independently associated with improved survival...
Chlamydophila psittaci eradication with doxycycline as first-line targeted therapy for ocular adnexae lymphoma: final results of an international phase II trialAndres J M Ferreri
San Raffaele Scientific Institute, Milan, Italy
J Clin Oncol 30:2988-94. 2012..To our knowledge, this is the first international phase II trial aimed at clarifying Cp prevalence and activity of first-line doxycycline in a homogeneous series of consecutive patients with newly diagnosed stage I OAMZL...
Therapeutic management of ocular adnexal MALT lymphomaAndres J M Ferreri
Medical Oncology Unit, Department of Oncology, San Raffaele Scientific Institute, Via Olgettina 6020132, Milan, Italy
Expert Opin Pharmacother 8:1073-83. 2007..In this review, the authors analyze related literature and propose therapeutic guidelines for the management of ocular adnexal lymphoma of MALT-type...
Intravascular lymphoma: a neoplasm of 'homeless' lymphocytes?Maurilio Ponzoni
Pathology Unit, San Raffaele H Scientific Institute, Milan, Italy
Hematol Oncol 24:105-12. 2006..The present review will discuss the most recent acquisitions related either to diagnosis and immunophenotypic/biologic characteristics as well as clinical/therapeutic issues of IVL...
Prevalence of Borrelia burgdorferi infection in a series of 98 primary cutaneous lymphomasMaurilio Ponzoni
Pathology Unit, Department of Onco Hematology, San Raffaele Scientific Institute, Milan, Italy
Oncologist 16:1582-8. 2011..burgdorferi in primary cutaneous B- and T-cell lymphomas from areas nonendemic for this microorganism and the consequent rationale for the adoption of antibiotic therapy in these patients...
Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomasAndres J M Ferreri
Department of Radiochemotherapy, San Raffaele H Scientific Institute, Via Olgettina 60, 20132 Milan, Italy
Br J Haematol 126:657-64. 2004..If confirmed in prospective trials on PCNSL treated with HD-MTX alone, these data may suggest the necessity for alternative strategies in M-PCNSL considering the increased risk of MTX resistance by tumour cells...
Primary central nervous system lymphomas: salvage treatment after failure to high-dose methotrexateMichele Reni
Medical Oncology Unit, Department of Oncology, San Raffaele Scientific Institute, Via Olgettina 60, 20132 Milan, Italy
Cancer Lett 258:165-70. 2007..High-dose chemotherapy supported by stem cell autotransplant and intrathecal chemotherapy in meningeal failure have to be further investigated in prospective trials...
Definition, diagnosis, and management of intravascular large B-cell lymphoma: proposals and perspectives from an international consensus meetingMaurilio Ponzoni
Unit of Lymphoma Malignancies, Pathology and Oncology Units, Department of Oncology, San Raffaele Scientific Institute, Milan, Italy
J Clin Oncol 25:3168-73. 2007..Finally, a provisional practical diagnostic approach to hemophagocytosis-associated patients and a proposal for the most useful criteria in the settings of differential diagnosis are included...
Prognostic value of bcl-6, CD10 and CD38 immunoreactivity in stage I-II gastric lymphomas: identification of a subset of CD10+ large B-cell lymphomas with a favorable outcomeMaurilio Ponzoni
Department of Pathology, San Raffaele H Scientific Institute, Milan, Italy
Int J Cancer 106:288-91. 2003..Accordingly, patients with CD10(+) gastric large B-cell lymphomas may be at reduced risk and eligible for clinical trials evaluating more conservative therapeutic options...
Immunoreactivity for cyclin D3 is frequently detectable in high-grade primary gastric lymphomas in the absence of the t(6;14)(p21.1;q32.3) chromosomal translocationGiancarlo Pruneri
Divisions of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy
J Pathol 200:596-601. 2003..000). These results suggest that the t(6;14) may represent a rare event in the pathogenesis of PGL and that cyclin D3 deregulation is most likely the result of epigenetic mechanisms...
A virtual tissue bank for primary central nervous system lymphomas in immunocompetent individualsMaurilio Ponzoni
Division of Pathology, Department of Oncology, San Raffaele Scientific Institute, Milan, Italy
Pathobiology 74:264-9. 2007..ielsg.org. Only anonymous data are centralized at the website of the International Extranodal Lymphoma Study Group, whilst the pathologic material is maintained at the local pathology institutes...
Central nervous system marginal zone B-cell lymphoma associated with Chlamydophila psittaci infectionMaurilio Ponzoni
Pathology Unit, San Raffaele Scientific Institute, 20132 Milan, Italy
Hum Pathol 42:738-42. 2011..This observation points toward the opportunity to investigate the prevalence of C psittaci infection in central nervous system lymphomas, particularly in those with low-grade histologic features...
Chronic idiopathic myelofibrosis: independent prognostic importance of bone marrow microvascular density evaluated by CD105 (endoglin) immunostainingMaurilio Ponzoni
Department of Pathology, San Raffaele H Scientific Institute, Milan, Italy
Mod Pathol 17:1513-20. 2004..These findings provide a rationale for the investigational use of anti-CD105-targeted drugs in CIMF...
Gastric lymphoma: the histology reportClaudio Doglioni
Department of Pathology, Scientific Institute San Raffaele, Milan, Italy
Dig Liver Dis 43:S310-8. 2011..This paper aims at giving the histopathologist a general knowledge about the state of art of this disease and its management. The diagnostic process leading to a complete and competent report is then described step by step...
Prognostic factors in primary central nervous system lymphomasAndres J M Ferreri
Medical Oncology Unit, Department of Oncology, San Raffaele H Scientific Institute, Via Olgettina 60, 20132 Milan, Italy
Hematol Oncol Clin North Am 19:629-49, vi. 2005..In the years ahead, a well-established prognostic score will allow the separation of patients into risk groups, which could result in the application of risk-tailored therapeutic strategies...
Salvage chemotherapy with temozolomide in primary CNS lymphomas: preliminary results of a phase II trialMichele Reni
Department of Radiochemotherapy, S Raffaele Hospital Scientific Institute, Milan, Italy
Eur J Cancer 40:1682-8. 2004..Although some patients had a poor PS and had been heavily pre-treated, temozolomide yielded 26% objective responses and was well tolerated without any major toxicity...
Ocular adnexal lymphoma: diffusion-weighted mr imaging for differential diagnosis and therapeutic monitoringLetterio S Politi
Department of Neuroradiology and Neuroradiology Research Unit, San Raffaele Scientific Institute, Via Olgettina 60, 20132 Milan, Italy it
Radiology 256:565-74. 2010....
Autoantibodies against a 72-kDa ductal cell membrane glycoprotein in a patient affected by Sjögren's syndrome and gastric MALT lymphomaF Folli
Department of Medicine I, I R C C S H S Raffaele, Via Olgettina, 60, 20132 Milan, Italy
Ann Hematol 81:597-602. 2002..Autoantibodies directed against this novel membrane autoantigen may be an additional serological marker in some cases of Sjögren's syndrome...
Primary brain CD30+ ALK1+ anaplastic large cell lymphoma ('ALKoma'): the first case with a combination of 'not common' variantsM Ponzoni
Departments of Pathology, S Raffaele H Scientific Institute, Milan, Italy
Ann Oncol 13:1827-32. 2002....
Area under the curve of methotrexate and creatinine clearance are outcome-determining factors in primary CNS lymphomasA J M Ferreri
Department of Radiochemotherapy, San Raffaele H Scientific Institute, Via Olgettina 60, Milan 20132, Italy
Br J Cancer 90:353-8. 2004..MTX dose adjustments in patients with fast CL(crea) should be investigated...
MATILDE regimen followed by radiotherapy is an active strategy against primary CNS lymphomasA J M Ferreri
Medical Oncology Unit, San Raffaele H Scientific Institute, Universita Vita Salute San Raffaele, Milan, Italy
Neurology 66:1435-8. 2006..Myelosuppression was the dose-limiting toxicity, with 9.5% of lethal complications. After a median follow-up of 49 months, a plateau in the survival curve (5-year overall survival: 41 +/- 7%) was obtained...
Temozolomide as salvage treatment in primary brain lymphomasM Reni
Medical Oncology Unit, Department of Oncology, San Raffaele Scientific Institute, Milan, Italy
Br J Cancer 96:864-7. 2007..Toxicity was negligible. We conclude that temozolomide is active in recurrent primary brain lymphomas and should further be evaluated in this disease, perhaps in combination with MTX as initial treatment...
Reactive perivascular T-cell infiltrate predicts survival in primary central nervous system B-cell lymphomasM Ponzoni
Pathology Unit, Unit of Lymphoid Malignancies, San Raffaele Scientific Institute, Milan, Italy
Br J Haematol 138:316-23. 2007..In conclusion, the presence of RPVI is independently associated with survival in PCNSL. This parameter can be easily and routinely assessed at diagnosis on histopathological specimens...
Role of 18FDG-PET/CT in detecting relapse during follow-up of patients with Hodgkin's lymphomaR Crocchiolo
Hematology and BMT Unit, San Raffaele Scientific Institute, Milan, Italy
Ann Hematol 88:1229-36. 2009..If FDG abnormal uptake is present at multiple nodal sites, subdiaphragmatic lymph nodes, or previous sites of disease, histological verification of PET abnormal findings is warranted...
Bone marrow histopathology in the diagnostic evaluation of splenic marginal-zone and splenic diffuse red pulp small B-cell lymphoma: a reliable substitute for spleen histopathology?Maurilio Ponzoni
Pathology Unit, Department of Oncology, San Raffaele Scientific Institute, Milan, Italy
Am J Surg Pathol 36:1609-18. 2012..However, presently it is not possible to distinguish SMZL from SDRL on the basis of BMB evaluation alone; hence, histopathologic examination of the spleen remains the "gold standard" approach...
